July 31, 2025 | 6:00 – 10:00 PM

• LEARNING OBJECTIVES

  At the conclusion of this activity, participants will be able to:

  • Evaluate the role of advanced AI-based imaging systems in early detection of retinal diseases, including diabetic retinopathy and age-related macular degeneration (AMD).
  • Identify the clinical applications of multimodal imaging techniques and their integration into therapeutic decision-making for retinal diseases.
  • Explain the significance of imaging-guided treatment monitoring and the impact of predictive analytics on therapy outcomes.
  • Discuss new imaging modalities, such as adaptive optics and high-resolution OCT, and their role in differential diagnosis of inherited retinal disorders.
  • Review the integration of imaging technologies with emerging gene and cell therapies, including latest developments in clinical trials of these therapies.

   

• TARGET AUDIENCE

  Retina specialists, retina fellows, ophthalmic photographers and healthcare providers who are interested in applying the most recent advancements in retinal imaging to the management of retinal diseases.

Fachärzte/-innen	Gebühren ab unbekannt
Ärzte/-innen in Weiterbildung	Gebühren ab unbekannt

Please contact the organiser for further information. 

 

Zertifizierung beantragt für CME Punkte bei der Sonstige
The symposium is accredited for a maximum of 3 AMA PRA Category 1 Credits™.